510(k) device
Remi
Epitel, Inc. · Reduced- Montage Standard Electroencephalograph (OMC, Class II) · First FDA decision Mar 29, 2021, newest Mar 29, 2021Epilepsy
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
510(k) pathway
Device trials
2
Naming "Remi"
MAUDE reports
24
Brand "Remi", since 2015
PubMed studies
441
Mentioning "Remi"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Remi
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
- REMI510(k)
K203827 · Decided Mar 29, 2021 · 90 days after receipt
Device type: Reduced- Montage Standard Electroencephalograph (OMC) · Neurology & Neurosurgery
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Hyperbaric Oxygen Therapy for Hypoxic Wounds and Diabetic Wounds of the Lower ExtremitiesNational analysisReview closedCAG-00060NUpdated Sep 14, 2026
- Varicose Veins of the Lower Extremity, Treatment ofLocal determinationIn effectL34082CGS Administrators, LLCUpdated Sep 29, 2026
- Wound Application of Cellular and/or Tissue Based Products (CTPs), Lower ExtremitiesLocal determinationIn effectL36690CGS Administrators, LLCUpdated Aug 28, 2026
- Varicose Veins of the Lower Extremity, Treatment ofLocal determinationIn effectL33575Wellpoint FederalUpdated Jul 14, 2026
- Nonvascular Extremity UltrasoundLocal determinationIn effectL33619Wellpoint FederalUpdated Jul 14, 2026
- Treatment of Varicose Veins of the Lower ExtremitiesLocal determinationIn effectL34209Noridian Healthcare Solutions, LLCUpdated May 5, 2026
- Non-invasive Arterial Duplex Ultrasound of the Upper and Lower ExtremitiesLocal determinationIn effectL40289First Coast Service Options, Inc.Updated Mar 27, 2026
- Non-invasive Arterial Duplex Ultrasound of the Upper and Lower ExtremitiesLocal determinationIn effectL40276Novitas Solutions, Inc.Updated Mar 27, 2026
Clinical trials
Device studies on ClinicalTrials.gov that name "Remi", any status and sponsor, newest update first.
University Hospital, LilleAcademic, hospital or other
NCT03556696 · 52 participants · Start Jun 27, 2018 · Primary completion Jun 14, 2022
Device: ANI-REMI-loop; remifentanil pK/pD target administration device and 1 more · For: Nociceptive Pain; Surgical Procedure, Unspecified
Sites: Lille, France
- Impact of Capturing Ictal Events With Ultra-long-term Ambulatory EEG Monitoring With Remote EEG Monitoring System.Status unknown
Epitel, Inc.Not on our public-company list
NCT06027749 · 65 participants (planned) · Start Oct 13, 2023 · Primary completion Mar 30, 2025
Device: Epitel's™ Remote EEG Monitoring System's (REMI™) · For: Epilepsy; Seizures
Sites: Tampa, Florida; Charleston, South Carolina
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Remi", and for the whole product code for context.
This brand
24 reports: 3 malfunction, 21 injury, 0 death
Whole product code OMC
8 reports: 6 malfunction, 2 injury, 0 death
Newest reports for this brand
- RemiInjury
3017575849-2026-00010 · Received Sep 23, 2026 · Event dated Aug 25, 2026
Device type: Mouthguard, Over-The-Counter (OBR)
Device problem as coded: Difficult to Remove
Patient problem as coded: Tooth Fracture
- REMIInjury
3014692331-2026-00001 · Received Aug 5, 2026 · Event dated Jul 13, 2026
Device type: Reduced- Montage Standard Electroencephalograph (OMC)
Device problem as coded: Appropriate Device Problem Term/Code Not Available
Patient problem as coded: Foreign Body In Patient
- REMIMalfunction
3017575849-2026-00009 · Received Jul 1, 2026 · Event dated Mar 12, 2026
Device type: Mouthguard, Over-The-Counter (OBR)
Device problem as coded: Device Emits Odor; Chemical Problem
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Remi"[tiab]. The summary above synthesizes these.
- LONG-REMI: An AI-Based Technological Application to Promote Healthy Mental Longevity Grounded in Reminiscence Therapy.
Nebot À, Domènech S, Albino-Pires N, et al. · Int J Environ Res Public Health · 2022Research Support, Non-U.S. Gov't
- [Redox Molecular Imaging Using ReMI].
Hyodo F, Ito S, Utsumi H · Yakugaku Zasshi · 2015English Abstract, Review
- Cheerfulness in the history of psychiatry.
Walusinski O, Fitzgerald A · Hist Psychiatry · 2024Historical Article
- Restriction enzyme-mediated integration (REMI) mutagenesis.
Kuspa A · Methods Mol Biol · 2006
- REMI-RFLP mapping in the Dictyostelium genome.
Kuspa A, Loomis WF · Genetics · 1994Research Support, U.S. Gov't, P.H.S.
- REMI: Reconstructing Episodic Memory During Intrinsic Path Planning.
Wang Z, Morris G, Derdikman D, et al. · ArXiv · 2025Preprint
- REMI: Reconstructing Episodic Memory During Internally Driven Path Planning.
Wang Z, Morris G, Derdikman D, et al. · bioRxiv · 2025Preprint
- Revision of the Melanocytic Pathology Assessment Tool and Hierarchy for Diagnosis Classification Schema for Melanocytic Lesions: A Consensus Statement.
Barnhill RL, Elder DE, Piepkorn MW, et al. · JAMA Netw Open · 2023Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
- Identification of novel proteins in the Dictyostelium discoideum chemorepulsion pathway using REMI.
Kirolos SA, Procaccia S, Groover KE, et al. · MicroPubl Biol · 2022
- Rémi W Bouchard, a pioneer in behavioural neurology.
Laforce R, Verret L, Poulin S, et al. · Lancet Neurol · 2017Biography, Historical Article
- Remi-fent 1-A pragmatic randomised controlled study to evaluate the feasibility of using remifentanil or fentanyl as sedation adjuncts in mechanically ventilated patients.
Rajamani A, Subramaniam A, Lung B, et al. · Crit Care Resusc · 2023
- SIRT2 overexpression decreases remifentanil-stimulated post-surgical hyperalgesia via microglia.
Zhu W, Ma Z · Cell Mol Biol (Noisy-le-grand) · 2023
Other devices of this type
Also filed under product code OMC.
- SignalNED System (Model RE)Forest Devices, Inc. · 510(k) 2025
- REMI Remote EEG Monitoring SystemEpitel · 510(k) 2025
- Ceribell MonitorCeribell, Inc. · 510(k) 2026
- NX01 (NX01)Naox Technologies Sas · 510(k) 2025
- Natus BrainWatch SystemNatus Medical Incorporated Dba Excel-Tech Ltd. (Xltek) · 510(k) 2024
- Quex EdQx World, Ltd. · 510(k) 2024
- NEBA® Compact EEG2R Mobile HeadsetNeba Health, LLC · 510(k) 2023
- Neurosteer EEG RecorderNeurosteer, Inc. · 510(k) 2022
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.